Log in to save to my catalogue

Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections

Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3218670

Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections

About this item

Full title

Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections

Publisher

United States: Oxford University Press

Journal title

The Journal of infectious diseases, 2011-11, Vol.204 (suppl_3), p.S1075-S1081

Language

English

Formats

Publication information

Publisher

United States: Oxford University Press

More information

Scope and Contents

Contents

The filoviruses, Marburg virus and Ebola virus, cause severe hemorrhagic fever with a high mortality rate in humans and nonhuman primates. Among the most-promising filovirus vaccines under development is a system based on recombinant vesicular stomatitis virus (rVSV) that expresses a single filovirus glycoprotein (GP) in place of the VSV glycoprote...

Alternative Titles

Full title

Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3218670

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3218670

Other Identifiers

ISSN

0022-1899

E-ISSN

1537-6613

DOI

10.1093/infdis/jir349

How to access this item